AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

PeRsonalized Blood prEssure Management on Postoperative Complications and Mortality in hIgh-risk Patients Undergoing Major Non-cardiac Surgery

RecruitingNAAges 65 Years - 90 YearsAllNanfang Hospital, Southern Medical University
💬

In plain words

What the trial is, and whether it could suit you

High-risk populations, particularly elderly individuals and patients with cardiovascular comorbidities, exhibit markedly elevated incidences of postoperative myocardial injury (MINS), acute kidney injury (AKI), and mortality. Intraoperative hypotension (IOH), a pervasive clinical phenomenon affecting 40%-90% of surgical cases, Substantial observational evidence links IOH severity/duration to ischemic organ injuries (MINS, AKI) and long-term morbidity.Nevertheless, inherent limitations of observational designs-particularly residual confounding-preclude definitive causal inferences. Notably, randomized controlled trials (RCTs) investigating goal-directed hemodynamic interventions demonstrate inconsistent clinical benefits, underscoring the imperative to clarify causal mechanisms between IOH and organ injury. This causal ambiguity arises from two unresolved scientific questions: (1) Thres

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Aged 65-90 yr; * Scheduled to undergo elective non-cardiac major surgery under general anesthesia (with an estimated surgery duration of ≥ 2 hours and an anticipated postoperative hospital stay of ≥ 2 days); * Patients with high cardiovascular risk, meeting at least one of the following conditions: 1. History of stroke; 2. History of coronary artery disease; 3. History of congestive heart failure; 4. History of peripheral arterial disease; 5. Preoperative brain natriuretic peptide (BNP) ≥ 92 mg/L or N-terminal pro-brain natriuretic peptide (NT-proBNP) ≥ 300 ng/L; 6. Preoperative cardiac troponin (cTn) or high-sensitivity cardiac troponin (hs-cTn) \> upper reference limit; 7. Hypertension requiring medication treatment; 8. Diabetes requiring medication treatment; 9. History of chronic kidney disease; 10. Continuous smoking for 2 years or more, with interruptions of less than one month before the current hospital admission; 11. Hypercholesterolemia; 12. History of transient ischemic attack. Exclusion Criteria: * Refuse to participate this trial; * Inability to communicate in the preoperative period because of coma, profound dementia, or language barrier; * Severe uncontrolled hypertension before surgery (systolic blood pressure ≥ 180 mmHg, diastolic blood pressure ≥ 110 mmHg); * Severe hepatic dysfunction (Child-Pugh Class C); or severe renal dysfunction required preoperative dialysis; or American Society of Anesthesiologists (ASA) physical status ≥ V; or expectation lifespan ≤ 24h; * Unstable cardiovascular conditions: acute coronary syndrome, decompensated heart failure, severe arrhythmias, severe valvular heart disease; * Scheduled to undergo neurosurgical procedures, transplantation, vascular surgery; * Urgent surgery; * Diagnosed with sepsis or sepsis shock before surgery. * Requiring vasopressor treatment before surgery. * Unable to finish 24-hour automated blood pressure monitor; * Current participation in another interventional study. * Any condition deemed ineligible for participation by clinicians.
💊

What it tests

  • Personalized blood pressure management
  • Routine blood pressure management
📍

Where

7 sites
Guangzhou First People's Hospital
Guangzhou, China
Nanfang Hospital, Southern Medical University
Guangzhou, China
The Affiliated Panyu Central Hospital of Guangzhou Medical University
Guangzhou, China
The Third People's Hospital of Shenzhen
Shenzhen, China
The Fifth Affiliated Hospital of Sun Yat-sen University
Zhuhai, China
The First Affiliated Hospital of Xi'an Jiaotong University
Xi’an, China
Sir Run Run Shaw Hospital
Hangzhou, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy